Journal article 1194 views 213 downloads

Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study

Berni Sewell, Mari Jones Orcid Logo, Helen Gray, Heather Wilkes, Catherine Lloyd-Bennett, Kim Beddow, Martin Bevan, Deborah Fitzsimmons Orcid Logo

British Journal of General Practice, Volume: 70, Issue: 692, Pages: e186 - e192

Swansea University Authors: Berni Sewell, Mari Jones Orcid Logo, Deborah Fitzsimmons Orcid Logo

  • 53256.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

    Download (107.74KB)

Check full text

DOI (Published version): 10.3399/bjgp20x708077

Abstract

Background: A pilot rapid diagnosis centre (RDC) allows GPs within targeted clusters to refer adults with vague and/or non-specific symptoms suspicious of cancer, who do not meet criteria for referral under an urgent suspected cancer (USC) pathway, to a multidisciplinary RDC clinic where they are se...

Full description

Published in: British Journal of General Practice
ISSN: 0960-1643 1478-5242
Published: Royal College of General Practitioners 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa53256
first_indexed 2020-01-14T19:34:06Z
last_indexed 2025-04-10T05:37:04Z
id cronfa53256
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-04-09T14:42:01.0260558</datestamp><bib-version>v2</bib-version><id>53256</id><entry>2020-01-14</entry><title>Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study</title><swanseaauthors><author><sid>f6a4af2cfa4275d2a8ebba292fa14421</sid><firstname>Berni</firstname><surname>Sewell</surname><name>Berni Sewell</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>8e326860810f5f960b088db10ef58906</sid><ORCID>0000-0001-9661-4899</ORCID><firstname>Mari</firstname><surname>Jones</surname><name>Mari Jones</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>e900d99a0977beccf607233b10c66b43</sid><ORCID>0000-0002-7286-8410</ORCID><firstname>Deborah</firstname><surname>Fitzsimmons</surname><name>Deborah Fitzsimmons</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-01-14</date><abstract>Background: A pilot rapid diagnosis centre (RDC) allows GPs within targeted clusters to refer adults with vague and/or non-specific symptoms suspicious of cancer, who do not meet criteria for referral under an urgent suspected cancer (USC) pathway, to a multidisciplinary RDC clinic where they are seen within 1 week. Aim: To explore the cost-effectiveness of the RDC compared with standard clinical practice. Design and setting: Cost-effectiveness modelling using routine data from Neath Port Talbot Hospital, Wales. Method: Discrete-event simulation modelled a cohort of 1000 patients from referral to radiological diagnosis based on routine RDC and hospital data. Control patients were those referred to a USC pathway but then downgraded. Published sources provided estimates of patient quality of life (QoL) and pre-diagnosis anxiety. The model calculates time to diagnosis, costs, and quality-adjusted life years (QALYs), and estimates the probability of the RDC being a cost-effective strategy. Results: The RDC reduces mean time to diagnosis from 84.2 days in usual care to 5.9 days if a diagnosis is made at clinic, or 40.8 days if further investigations are booked during RDC. RDC provision is the superior strategy (that is, less costly and more effective) compared with standard clinical practice when run near or at full capacity. However, it is not cost-effective if capacity utilisation drops below 80%. Conclusion: An RDC for patients presenting with vague or non-specific symptoms suspicious of cancer in primary care reduces time to diagnosis and provides excellent value for money if run at &#x2265;80% capacity.</abstract><type>Journal Article</type><journal>British Journal of General Practice</journal><volume>70</volume><journalNumber>692</journalNumber><paginationStart>e186</paginationStart><paginationEnd>e192</paginationEnd><publisher>Royal College of General Practitioners</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0960-1643</issnPrint><issnElectronic>1478-5242</issnElectronic><keywords>cancer diagnosis; cost-effectiveness; early detection of cancer; general practice; nonspecific symptoms; rapid diagnosis centre</keywords><publishedDay>1</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-03-01</publishedDate><doi>10.3399/bjgp20x708077</doi><url/><notes/><college>COLLEGE NANME</college><CollegeCode>COLLEGE CODE</CollegeCode><institution>Swansea University</institution><apcterm/><funders>Cancer Research UK (CRUK)</funders><projectreference/><lastEdited>2025-04-09T14:42:01.0260558</lastEdited><Created>2020-01-14T14:15:32.0392994</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Health and Social Care - Public Health</level></path><authors><author><firstname>Berni</firstname><surname>Sewell</surname><order>1</order></author><author><firstname>Mari</firstname><surname>Jones</surname><orcid>0000-0001-9661-4899</orcid><order>2</order></author><author><firstname>Helen</firstname><surname>Gray</surname><order>3</order></author><author><firstname>Heather</firstname><surname>Wilkes</surname><order>4</order></author><author><firstname>Catherine</firstname><surname>Lloyd-Bennett</surname><order>5</order></author><author><firstname>Kim</firstname><surname>Beddow</surname><order>6</order></author><author><firstname>Martin</firstname><surname>Bevan</surname><order>7</order></author><author><firstname>Deborah</firstname><surname>Fitzsimmons</surname><orcid>0000-0002-7286-8410</orcid><order>8</order></author></authors><documents><document><filename>53256__16862__413ee96319c84d43a4f74b3c62fd7c21.pdf</filename><originalFilename>53256.pdf</originalFilename><uploaded>2020-03-17T11:57:31.7437457</uploaded><type>Output</type><contentLength>110324</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2025-04-09T14:42:01.0260558 v2 53256 2020-01-14 Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study f6a4af2cfa4275d2a8ebba292fa14421 Berni Sewell Berni Sewell true false 8e326860810f5f960b088db10ef58906 0000-0001-9661-4899 Mari Jones Mari Jones true false e900d99a0977beccf607233b10c66b43 0000-0002-7286-8410 Deborah Fitzsimmons Deborah Fitzsimmons true false 2020-01-14 Background: A pilot rapid diagnosis centre (RDC) allows GPs within targeted clusters to refer adults with vague and/or non-specific symptoms suspicious of cancer, who do not meet criteria for referral under an urgent suspected cancer (USC) pathway, to a multidisciplinary RDC clinic where they are seen within 1 week. Aim: To explore the cost-effectiveness of the RDC compared with standard clinical practice. Design and setting: Cost-effectiveness modelling using routine data from Neath Port Talbot Hospital, Wales. Method: Discrete-event simulation modelled a cohort of 1000 patients from referral to radiological diagnosis based on routine RDC and hospital data. Control patients were those referred to a USC pathway but then downgraded. Published sources provided estimates of patient quality of life (QoL) and pre-diagnosis anxiety. The model calculates time to diagnosis, costs, and quality-adjusted life years (QALYs), and estimates the probability of the RDC being a cost-effective strategy. Results: The RDC reduces mean time to diagnosis from 84.2 days in usual care to 5.9 days if a diagnosis is made at clinic, or 40.8 days if further investigations are booked during RDC. RDC provision is the superior strategy (that is, less costly and more effective) compared with standard clinical practice when run near or at full capacity. However, it is not cost-effective if capacity utilisation drops below 80%. Conclusion: An RDC for patients presenting with vague or non-specific symptoms suspicious of cancer in primary care reduces time to diagnosis and provides excellent value for money if run at ≥80% capacity. Journal Article British Journal of General Practice 70 692 e186 e192 Royal College of General Practitioners 0960-1643 1478-5242 cancer diagnosis; cost-effectiveness; early detection of cancer; general practice; nonspecific symptoms; rapid diagnosis centre 1 3 2020 2020-03-01 10.3399/bjgp20x708077 COLLEGE NANME COLLEGE CODE Swansea University Cancer Research UK (CRUK) 2025-04-09T14:42:01.0260558 2020-01-14T14:15:32.0392994 Faculty of Medicine, Health and Life Sciences School of Health and Social Care - Public Health Berni Sewell 1 Mari Jones 0000-0001-9661-4899 2 Helen Gray 3 Heather Wilkes 4 Catherine Lloyd-Bennett 5 Kim Beddow 6 Martin Bevan 7 Deborah Fitzsimmons 0000-0002-7286-8410 8 53256__16862__413ee96319c84d43a4f74b3c62fd7c21.pdf 53256.pdf 2020-03-17T11:57:31.7437457 Output 110324 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). true eng https://creativecommons.org/licenses/by-nc/4.0/
title Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
spellingShingle Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
Berni Sewell
Mari Jones
Deborah Fitzsimmons
title_short Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
title_full Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
title_fullStr Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
title_full_unstemmed Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
title_sort Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study
author_id_str_mv f6a4af2cfa4275d2a8ebba292fa14421
8e326860810f5f960b088db10ef58906
e900d99a0977beccf607233b10c66b43
author_id_fullname_str_mv f6a4af2cfa4275d2a8ebba292fa14421_***_Berni Sewell
8e326860810f5f960b088db10ef58906_***_Mari Jones
e900d99a0977beccf607233b10c66b43_***_Deborah Fitzsimmons
author Berni Sewell
Mari Jones
Deborah Fitzsimmons
author2 Berni Sewell
Mari Jones
Helen Gray
Heather Wilkes
Catherine Lloyd-Bennett
Kim Beddow
Martin Bevan
Deborah Fitzsimmons
format Journal article
container_title British Journal of General Practice
container_volume 70
container_issue 692
container_start_page e186
publishDate 2020
institution Swansea University
issn 0960-1643
1478-5242
doi_str_mv 10.3399/bjgp20x708077
publisher Royal College of General Practitioners
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Health and Social Care - Public Health{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Health and Social Care - Public Health
document_store_str 1
active_str 0
description Background: A pilot rapid diagnosis centre (RDC) allows GPs within targeted clusters to refer adults with vague and/or non-specific symptoms suspicious of cancer, who do not meet criteria for referral under an urgent suspected cancer (USC) pathway, to a multidisciplinary RDC clinic where they are seen within 1 week. Aim: To explore the cost-effectiveness of the RDC compared with standard clinical practice. Design and setting: Cost-effectiveness modelling using routine data from Neath Port Talbot Hospital, Wales. Method: Discrete-event simulation modelled a cohort of 1000 patients from referral to radiological diagnosis based on routine RDC and hospital data. Control patients were those referred to a USC pathway but then downgraded. Published sources provided estimates of patient quality of life (QoL) and pre-diagnosis anxiety. The model calculates time to diagnosis, costs, and quality-adjusted life years (QALYs), and estimates the probability of the RDC being a cost-effective strategy. Results: The RDC reduces mean time to diagnosis from 84.2 days in usual care to 5.9 days if a diagnosis is made at clinic, or 40.8 days if further investigations are booked during RDC. RDC provision is the superior strategy (that is, less costly and more effective) compared with standard clinical practice when run near or at full capacity. However, it is not cost-effective if capacity utilisation drops below 80%. Conclusion: An RDC for patients presenting with vague or non-specific symptoms suspicious of cancer in primary care reduces time to diagnosis and provides excellent value for money if run at ≥80% capacity.
published_date 2020-03-01T10:54:43Z
_version_ 1831726883515924480
score 11.058631